Heat Biologics, Inc. (HTBX) belonging to the Medical sector has surged 4.35% and closed its last trading session at $0.96.
The company reported its EPS on 03/09/2017. Currently, the stock has a 1 Year Price Target of $4.
The consensus recommendation, according to Zacks Investment research, is 1. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 1 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 1 and 1 respectively.
Heat Biologics, Inc. on 03/09/2017 reported its EPS as $-0.08 with the analysts projecting the EPS of the stock as $-0.15. The company beat the analyst EPS Estimate with the difference of $0.07. This shows a surprise factor of 46.7%.
Many analysts have provided their estimated foresights on Heat Biologics, Inc. Earnings, with 1 analysts believing the company would generate an Average Estimate of $-0.07.
Whereas they predicted High and Low Earnings Estimate as $-0.07 and $-0.07 respectively. While in the same Quarter Previous year, the Actual EPS was $-0.78.
Analysts are also projecting an Average Revenue Estimate for Heat Biologics, Inc. as $130 Million in the Current Quarter. This estimate is provided by 1 analysts.
The Company got Initiated by ROTH Capital on 20-Jun-16 to Buy.
Insider Trades for Heat Biologics, Inc. show that the latest trade was made on 6 Feb 2017 where Rosar (Ann A), the Officer completed a transaction type “Sell” in which 6764 shares were traded at a price of $0.88.
1 analysts projected Price Targets for Heat Biologics, Inc.. The analysts believe that the company stock price could grow as high as $4. The Low Price target projection by analysts is $4 and the Mean Price Target is $4.
Heat Biologics, Inc. (HTBX) has the market capitalization of $25.92 Million. The company rocked its 52-Week High of $3.35 on Nov 29, 2016 and touched its 52-Week Low of $0.4 on May 13, 2016.
The stock has Return on Assets (ROA) of -140.5 percent. Return on Equity (ROE) stands at -316% and Return on Investment (ROI) of 0 percent.
The stock is currently showing YTD performance of 11.63 Percent. The company has Beta Value of 0.78 and ATR value of 0.09. The Weekly and Monthly Volatility stands at 13.07% and 9.44%.